Clinical Improvement in Ankylosing Spondylitis with Rifamycin SV Infiltrations of Peripheral Joints

Journal of International Medical Research

Volumn 20, Issue 2, 1992, Pages 171-181

  Caruso, I ^a   Cazzola, M ^a   Santandrea, S ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Ankylosing spondylitis; Intra articular administration; Rifamycin SV

Indexed keywords

C REACTIVE PROTEIN; RIFAMYCIN;

ADOLESCENT; ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BLOOD CHEMISTRY; CLINICAL ARTICLE; DRUG ADMINISTRATION; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATION; INTRAARTICULAR DRUG ADMINISTRATION; JOINT MOBILITY; MALE; MORNING STIFFNESS; ORAL DRUG ADMINISTRATION; PAIN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; FEMALE; HUMAN; INFLAMMATION; INJECTIONS, INTRA-ARTICULAR; MALE; PAIN; RIFAMPIN; RIFAMYCINS; SPONDYLITIS, ANKYLOSING; SUPPORT, NON-U.S. GOV'T;

EID: 0026594789     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/030006059202000209     Document Type: Article

References (12)

1. Caruso I Montrone F Fumagalli M Rheumatoid knee synovitis successfully treated with intra-articular rifamycin SV. Ann Rheum Dis 1982; 41: 232–236.
2. Caruso I Montrone F Fumagalli M Rifamycin SV in the treatment of knee synovitis. Orthopedics 1982; 5: 1336–1343.
3. Caruso I Fumagalli M Montrone F Clinical remission in rheumatoid patients induced by intra-articular rifamycin SV [Abstract]. Clin Rheumatol 1984; 3: 111.
4. Moll JMH Wright V New York clinical criteria for ankylosing spondylitis: A statistical evaluation. Ann Rheum Dis 1973; 32: 354–363.
5. Sheehan NJ Slavin Donovan MP Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase proteins or protease inhibitors in ankylosing spondylitis. Br J Rheumatol 1986; 25: 171–174.
6. Moll JMH Wright V Normal range of spinal mobility: An objective clinical study. Ann Rheum Dis 1971; 30: 381–386.
7. Mielants H Veys EM Joos K Sulphasalazine (salazopyrin) in the treatment of enterogenic reactive arthritis and ankylosing spondylitis with peripheral arthritis. Clin Rheumatol 1986; 5: 80–83.
8. Feltelius N Hällgren K Sulfasalazine in ankylosing spondylitis. Ann Rheum Dis 1986; 45: 396–399.
9. Dougados M Boumier P Amor B Sulfasalazine in ankylosing spondylitis: A double-blind controlled study in 60 patients. Br Med J 1986; 293: 911–914.
10. Nissilä M Lehtinen K Leirisalo-Repo M Sulfasalazine in the treatment of ankylosing spondylitis. Arthritis Rheum 1988; 31: 1111–1116.
11. Ebringer A The cross-tolerance hypothesis, HLA-B27 and ankylosing spondylitis. Br J Rheumatol 1983; 22 (suppl 2): 53–56.
12. Spisani S Dovigo L Corazzo G The effect of rifamycin SV on neutrophil functions in patients with rheumatoid arthritis. Scand J Rheumatol 1982; 11: 65–69.